title: New drugs 2015, part 2.
authors.affiliation: Remington Professor of Pharmacy Philadelphia College of Pharmacy University of the Sciences Philadelphia, Pa.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D001572:Benzofurans / Q000627:therapeutic use; D003521:Cyclopropanes / Q000627:therapeutic use; D011756:Diphosphates / Q000627:therapeutic use; D017277:Drug Approval; D004358:Drug Therapy / Q000451:nursing*; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives / Q000627:therapeutic use; D005960:Glucosides / Q000627:therapeutic use; D006020:Glycopeptides / Q000627:therapeutic use; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D000077427:Lipoglycopeptides; D010755:Organophosphates / Q000627:therapeutic use; D010080:Oxazoles / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D013431:Sulfates / Q000627:therapeutic use; D017334:Teicoplanin / Q000031:analogs & derivatives / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D014640:Vancomycin / Q000031:analogs & derivatives
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D001559:Benzhydryl Compounds; D001572:Benzofurans; D003521:Cyclopropanes; D011756:Diphosphates; D052216:Glucagon-Like Peptide 1; D005960:Glucosides; D006020:Glycopeptides; D007783:Lactones; D000077427:Lipoglycopeptides; D010755:Organophosphates; D010080:Oxazoles; D011725:Pyridines; D013431:Sulfates; D017334:Teicoplanin; C534611:rGLP-1 protein; C469289:dalbavancin; C543529:vedolizumab; C570240:empagliflozin; C515040:tedizolid phosphate; C100708:oritavancin; D014640:Vancomycin; C478745:tasimelteon; C530299:vorapaxar